Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-023313
Filing Date
2024-09-12
Accepted
2024-09-12 18:00:51
Documents
1
Period of Report
2024-09-11

Document Format Files

Seq Description Document Type Size
1 form4-09122024_100948.html 4  
1 form4-09122024_100948.xml 4 3384
  Complete submission text file 0001415889-24-023313.txt   4799
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Issuer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512
Business Address
Jalota Deepika (Reporting) CIK: 0001825192 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39539 | Film No.: 241295938